Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
Clinical trial NCT03731234 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03731234
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-02
- Primary completion
- 2024-07-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.